Show simple item record

dc.contributor.authorDorsey, S.G.
dc.date.accessioned2019-04-05T13:55:09Z
dc.date.available2019-04-05T13:55:09Z
dc.date.issued2018
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85033470294&doi=10.1007%2fs13311-017-0584-1&partnerID=40&md5=d41c8613c997dab8290d92a69e59b79c
dc.identifier.urihttp://hdl.handle.net/10713/8766
dc.description.abstracten_US
dc.description.urihttps://dx.doi.org/10.1007/s13311-017-0584-1en_US
dc.language.isoEnglishen_US
dc.publisherSpringer New York LLCen_US
dc.relation.ispartofNeurotherapeutics
dc.subjectchemotherapy-induced peripheral neuropathyen_US
dc.subject.meshColorectal Neoplasms--drug therapyen_US
dc.subject.meshMolecular Chaperones--antagonists & inhibitorsen_US
dc.subject.meshOxaliplatin--adverse effectsen_US
dc.subject.meshPeripheral Nervous System Diseasesen_US
dc.titleSelective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathyen_US
dc.typeNoteen_US
dc.identifier.doi10.1007/s13311-017-0584-1
dc.identifier.pmid29110212


This item appears in the following Collection(s)

Show simple item record